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Polycyclic aromatic hydrocarbons (PAHs) such as benzo[a]
pyrene (BaP) are immunotoxic to fish. Metabolism of PAHs in
immune cells has been implicated in PAH immunotoxicity in
mammals, but for fish the presence of metabolic enzymes in im-
mune cells is less clear. The objective of this study was to examine
localization and induction of the BaP-metabolizing biotransfor-
mation enzyme, cytochrome P4501A (CYP1A), in head kidney
immune cells of rainbow trout (Oncorhynchus mykiss). In the first
step, we measured induction of CYP1A-dependent 7-ethoxyresor-
ufin-O-deethylase (EROD) activity and CYP1A protein in head
kidney of rainbow trout treated with a single intraperitoneal (ip)
injection of 25 mg BaP/kg body weight. From days 3 to 10 post-
injection, the BaP treatment led to a significant elevation of
EROD and CYP1A protein in head kidney and liver, with CYP1A
expression levels in the head kidney being much lower than in the
liver. Next, we examined the cellular localization of CYP1A
protein in the head kidney cell types: vascular endothelial, endo-
crine and lymphoid cells. CYP1A immunoreactivity was detect-
able only in BaP-treated trout, where it was localized in
endothelial and lymphoid cells. Finally, we aimed to clarify which
of the hematopoietic cell types possess CYP1A protein. Using
double immunostaining for CYP1A and surface markers of
rainbow trout immune cells, we identified B lymphocytes and
granulocytes expressing inducible CYP1A protein and being the
likely sites of BaP metabolism in the head kidney.
Key Words: rainbow trout; benzo[a]pyrene; immunotoxicity;
cytochrome P4501A; granulocytes; B lymphocytes.
The immune system of fish is responsive to toxicants (Rice,
2001; Segner et al., 2006; Zelikoff, 1994). Field studies have
shown that fish from polluted sites show decreased immune
responses compared with fish collected from less polluted or
pristine areas (e.g., Arkoosh et al., 1998; Faisal et al., 1991;
Secombes et al., 1995; Weeks et al., 1990). Also in the labo-
ratory, an impact of toxic chemicals on the fish immune system
has been demonstrated (e.g., Aaltonen et al., 2000; Baier-
Anderson and Anderson, 2000; Hoeger et al., 2004; Karrow
et al., 1999). Because the immune system is vital for the fish’s
defense against infectious agents, impairment of immune func-
tions by environmental pollutants can critically affect fish
health and subsequently population growth (Springman et al.,
2005; Spromberg and Meador, 2005).
One class of environmental contaminants that modifies the
fish immune system are polycyclic aromatic hydrocarbons
(PAHs). PAH exposure has been shown to be associated with
immunosuppressive effects such as reduced phagocytic and
respiratory burst activity of macrophages (Weeks and
Warinner, 1984, 1986; Weeks et al., 1986), reduced total
white blood cell count and impaired mitogen-stimulated T- and
B-lymphocyte proliferation (Carlson, 2001; Carlson et al.,
2002a; Hart et al., 1998; Lemaire-Gony et al., 1995; Reynaud
et al., 2001). These PAH-induced immune functional changes
can be associated with decreased resistance of the fish against
pathogen infection (Carlson et al., 2002b; Palm et al. 2003).
The mechanisms underlying the PAH modulatory effects on
the fish immune system are essentially unknown.
To exert their toxic effects, most PAHs require activation by
biotransformation enzymes, particularly by members of the
cytochrome P4501 family. In fact, in mammals the ability of
immune cells to metabolize PAHs has been implicated in PAH
immunotoxicity (Krovat et al., 2000; Galván et al., 2006;
Miller and Ramos, 2001; Mounho et al., 1997), although addi-
tional mechanisms of action appear to be operating (Laupeze
et al., 2002; Uno et al., 2006). Particular attention in research
on PAH metabolism and immunotoxicity has been given to
cytochrome P4501A, which is mainly expressed in the liver but
also in immune cells (Davila et al., 1996; Grevenynghe et al.,
2003). However, the role of other enzymes of the cytochrome
P4501 family must not be overlooked. For instance, PAH
toxicity to the bone marrow that leads to death of progenitor B
cells and, as a consequence, to impaired humoral immunity
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appears to depend on the cytochrome P4501B1–dependent
PAH metabolism (Galván et al., 2003, 2005).
For teleost fish, published findings on the expression of
biotransformation enzymes in immune cells and hematopoietic
tissues are conflicting. Two recent immunohistochemical stud-
ies described the presence of teleostean cytochrome P4501A
(CYP1A) in immune cells of the excretory kidneys of
European flounder, Platichthys flesus (Grinwis and van den
Brandhof, 2001; Grinwis et al., 2000) and medaka, Oryzias
latipes (Carlson et al., 2004a), whereas studies on scup,
Stenostomus chrysops (Smolowitz et al., 1991; Stegeman et al.,
1991), zebrafish, Danio rerio (Buchmann et al., 1993), and
cod, Gadus morhua (Husøy et al., 1994) found no CYP1A-
positive immune cells in the excretory kidneys. Immune cells
in the spleen of medaka were negative for CYP1A (Carlson
et al., 2004a). Whether immune cells in the head kidney, which
is a major immune organ of fish, express CYP1A is not clear
yet. Biochemical studies have demonstrated PAH-inducible
CYP1A activity in homogenates of head kidney (Carlson et al.,
2004a; Marionnet et al., 1997; Pesonen et al., 1990; Quabius
et al., 2002; Taysse et al., 1998), however, because the head
kidney is a heterogenous tissue containing endocrine (in-
terrenal and chromaffin) and vascular endothelial cells in
addition to lymphoid cells, this does not prove that CYP1A is
localized in the immune cells. Husøy et al. (1994) who studied
cellular distribution of CYP1A in the head kidney, found that
CYP1A immunoreactivity was restricted to the interrenal cells,
whereas vascular endothelia and lymphoid cells were negative.
Given the controversial findings on CYP1A expression in
piscine immune cells, the present study aims to characterize
localization and induction of CYP1A in immune cells of the
head kidney of rainbow trout, Oncorhynchus mykiss. More
specifically, we address the following questions: (1) how do
basal and induced levels of CYP1A activity and CYP1A protein
in head kidney compare to liver as reference organ for CYP1A
induction? To answer this question, we exposed rainbow trout
to benzo[a]pyrene (BaP) as a prototypic metabolizable and
immunotoxic PAH. Time-dependent induction of CYP1A
enzyme activity in liver and head kidney was determined by
measuring CYP1A-associated 7-ethoxyresorufin-O-deethylase
(EROD) activity, whereas CYP1A protein levels were esti-
mated using Western Blot. (2) Which cell types of trout head
kidney—endocrine cells, vascular endothelial cells, lymphoid
cells—express CYP1A protein? The cellular CYP1A localiza-
tion was assessed by means of immunohistochemistry. (3)
Which immune cell population in trout head kidney expresses
CYP1A protein? To study this question, we employed double
immunostaining on surface marker-defined leukocytes isolated
from head kidney of control and BaP-exposed rainbow trout.
MATERIALS AND METHODS
Fish and BaP exposure experiment. Adult female rainbow trout
(O. mykiss) of 440 ± 86 g body weight were selected from the stock population
reared at the Centre for Fish and Wildlife Health, University of Berne. One
week before the experiment fish (n ¼ 56) were transferred and distributed
randomly to eight glass aquaria of 200 l volume (seven fish per 200 l). The fish
were kept under flow-through conditions (0.5 l/min) in air-saturated tap water
(total hardness (CaCO3): 2.13 ppm; chlorine dioxide: <0.01 mg/l) and at
a water temperature of 15 ± 1C. During the acclimatization and the
experimental period, the fish were fasted.
After the acclimatization period of one week, one fish per aquarium was
sampled (n ¼ 8 total) for histological and biochemical analyses (day 0).
Afterward, from each aquarium three fish received a single ip injection of
25 mg BaP per kg body weight. The BaP (98% high performance liquid chro-
matography purity, 99.5 lmol BaP/kg; Fluka, Switzerland) was dissolved in
50C warm corn oil at a concentration of 50 mg/ml BaP. The three remaining
fish per tank received an injection of carrier corn oil only. For the injection, the
fish were slightly anesthetized, and after injection, they passed through a bath
tank in order to remove traces of the contaminant, which may leak out from the
injection site. The BaP-injected and the corn oil-injected fish were discrimi-
nated by means of fin incisions. Three, 6 and 10 days postinjection (p.i.), one
BaP-treated and one control fish were sampled from each of the eight replicate
tanks (n ¼ 8 fish per treatment and day).
Sampling of tissues. The fish were anesthetized for 2 min in buffered
3-aminobenzoic acid ethyl ester (MS-222, Sandoz LTD, Basel, Switzerland).
The anesthetized fish were killed by a blow to the head, and head kidney as
well as liver were dissected. Bile was collected from the gall bladder with
a syringe and stored in light-protected tubes at 80C until analysis. For
biochemical analyses, tissue specimens were shock-frozen in liquid nitrogen
before storage at 80C. For histological and immunohistochemical analyses,
tissues were fixed in Bouin’s solution (without glacial acetic acid). After 24 h of
fixation at room temperature, tissues were transferred into 70% ethanol and
stored at 4C before routine processing for paraffin embedding and sectioning.
EROD activities. EROD activities of head kidney and liver were
determined as described by Scholz and Segner (1999). In brief, tissue pieces
(0.8 g) were homogenized on ice using a potter in 6 ml of homogenization
buffer (50mM Tris, 0.25M saccharose, 2mM Na2-ethylenediaminetetracacetic
acid, 150mM KCl, 1mM dithiotreitol, 0.25mM phenylmethylsulfonyl fluoride;
pH 7.8). The homogenate was centrifuged at 10,000 3 g at 4C for 20 min in
a Beckman low speed centrifuge (J2-MC). The supernatant was carefully
removed and centrifuged for 1 h at 100,000 3 g at 4C in a Centrikon
ultracentrifuge (T-2070). The pellet containing the microsomal fraction was
resuspended in EROD buffer (80mM Na2HPO4, 20mM KH2PO4, 150mM KCl,
20% glycerine; pH 7.8). The buffer volume was 100 ll for head kidney
microsomes and 400 ll for liver microsomes. The microsomes were used for
EROD analysis as well as Western blotting (see below).
EROD activities were measured in a fluorescence plate reader (Multilable
Counter 1420-011 VICTOR2). In the wells of opaque microtiter plates, 250 ll
of EROD buffer containing 47 lM beta-nicotinamide adenine dinucleotide
phosphate (reduced) (Sigma, Switzerland) and 0.5 lM ethoxyresorufin (7-
ethoxy-3H-phenoxazin-3-one-resorufin-ethylether, Sigma) were mixed with
either 2.5, 5, or 10 ll sample and the amount of resorufin produced during
3 min at 21C was determined at the excitation wavelength of 544 nm and at
the emission wavelength of 590 nm. Each sample was analyzed at three protein
concentrations (2.5-, 5-, and 10-ll sample volume) and each sample volume
was measured in duplicate. The mean value was used for following calcu-
lations. The reaction velocity was calculated from the linear portion of the
reaction curve and was transformed into pmol resorufin using a resorufin
standard curve established by determining the fluorescence of serial resorufin
concentrations (7-hydroxy-3H-phenoxazin-3-one, Sigma; 62.5–500 nM). EROD
activity was expressed as pmol of resorufin formed per minute per milligram
microsomal protein. Microsomal protein was determined by AMIDO BLACK
Protein Assay according to the recommendations of the manufacturer (Merck,
Darmstadt, Germany).
Quantification of BaP metabolites in bile. Bile was diluted 1:2000 with
double distilled water in light-protected tubes. In the wells of opaque microtitre
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plates, 300 ll of the dilution were analyzed at the excitation wavelength of 380
nm and at the emission wavelength of 430 nm (Aas et al., 2000). Measurements
were made in a fluorescence plate reader (Multilable Counter 1420-011
VICTOR2).
Western blot analysis of CYP1A in head kidney and liver. Microsomal
samples obtained as described above were dissolved in 63 sodium dodecyl
sulfate (SDS) sample buffer (Laemmli, 1970) and heated at 95C for 5 min.
Equal amounts of protein were separated on a one-dimensional 10% poly-
acrylamide gel under standard denaturing conditions according to the method
of Laemmli (1970). As protein weight marker Broadrange Standard (SDS-
PAGE Standards, range 21.5–200 kDa, Bio-Rad, Hercules, CA) was used. The
proteins were then electroblotted onto nitrocellulose membranes and incubated
overnight at 4C with a mouse monoclonal antibody (mAb) against rainbow
trout CYP1A (peptide 277–294, C10-7, Biosense Laboratories AS, Norway)
diluted 1:200. After several washes in TBS-T buffer, the blots were incubated
for 45 min with a 1:2000 dilution of horseradish peroxidase–conjugated rabbit
anti-mouse IgG as secondary antibody (Amersham international, Amersham,
UK). After intensification with horseradish peroxidase–conjugated anti-rabbit
IgG (Amersham), diluted 1:500, the blots were visualized on preflashed X-ray
film with a Super Signal Substrate Western Blotting (Pierce, Rockford, IL).
CYP1A immunohistochemistry on liver and head kidney tissue
sections. Five-micrometer paraffin sections were rehydrated and endogenous
peroxidase activity was blocked by treatment with 2% H2O2 (in ethanol) for 5 min
at room temperature. Then, sections were transferred for 5 min to phosphate
buffered saline (PBS) with Triton X-100 (PBS-T) and saturated in PBS-T with
0.5% casein for 30 min. Sections were incubated overnight in a moist chamber
at room temperature with the C10-7 mAb directed against CYP1A diluted 1:200
in PBS-T containing 0.5% casein and 1% DMSO. For the further steps,
a peroxidase ABC-staining kit (Vectastain, Vector Labs, Burlingame, CA) was
used. In brief, after several washes in PBS-T, sections were incubated for 1 h at
room temperature with biotinylated anti-mouse IgG (ABC-kit) diluted 1:200 in
PBS-T–1% horse serum. Sections were washed again and then incubated for 1 h
at room temperature with an avidin-biotinylated horseradish peroxidase complex
(ABC-kit). Finally, sections were washed with PBS-T followed by the application
of peroxidase substrate (3,3# diaminobenzidine, Sigma) dissolved in Tris–HCl
(0.05M, pH 7.4). Negative controls were incubated with PBS instead of the
primary antibody. Counterstaining was done using acid hemalaun.
Double immunostaining for CYP1A and immune cell surface markers on
isolated head kidney leukocytes. For double immunofluorescence staining of
isolated head kidney cells, additional rainbow trout were injected with either
corn oil or BaP (25 mg/kg body weight) dissolved in corn oil. Six days p.i., the
fish were sacrificed and head kidney leukocytes were prepared using Ficoll
separation solution (Biochrom AG, Berlin, Germany). The resulting leucocyte
suspension was adjusted to 1 3 107 cells/ml. The leukocytes were incubated for
20 min at 4C with a mouse mAb directed either against rainbow trout granu-
locytes (mAbQ4E; Kuroda et al., 2000) or against rainbow trout B lymphocytes
(mAb4C10, Thuvander et al., 1990; mAbN2, Fischer and Köllner, 1994). After
repeated washes by centrifugation with PBS, leukocytes were incubated with
Texas red-conjugated anti-mouse IgG (Molecular Probes Europe, Juro Supply
AG, Switzerland) for 1 h and fixed with 3% paraformaldehyde and 2% sucrose
in PBS. For CYP1A immunostaining, cytospins were prepared using 80 ll of
the cell suspension, and the cells permeabilized using microwave (160 W, 10
min). Nonspecific staining was blocked by incubation in PBS containing 3%
bovine serum albumin for 1 h. Intracellular labeling of CYP1A was achieved
by incubating the cells with a rabbit polyclonal antibody against fish CYP1A
(1:100 diluted, CP 226, Biosense Laboratories AS) in a humid chamber at 4C
overnight. After repeated washing in PBS, visualization of CYP1A was
achieved by staining with fluorescence isothiocyanate (FITC)-labeled anti-
rabbit IgG (1:1500 diluted, Jackson ImmunoResearch, West Grove, PA, USA)
for 1 h. In addition to immunohistochemical staining, nuclear staining was done
by means of 4#,6-diamidine-2#-phenylindole dihydrochloride (DAPI, 0.5 lg/ml)
(Roche, Mannheim, Germany).
Statistics. The data were initially tested for normality and homogeneity
with the one-sample Kolmogorov–Smirnov test. Because the data were not
normally distributed, results were calculated with the Mann–Whitney U test
(nonparametric tests of Kruskal–Wallis, one-way analysis). Correlation
analyses were made by the Pearson correlation test.
RESULTS
EROD Activity in Head Kidney and Liver Microsomes
Catalytic EROD activities in the head kidney of untreated
control fish were 0.66, 0.50, 0.50, and 0.35 pmol resorufin/min/
mg protein at days 0, 3, 6, and 10, respectively. There was no
statistically significant difference of control values between the
different days of sampling. In fish injected with BaP (25 mg/kg
body weight) EROD activities of the head kidney (Fig. 1A)
were significantly increased over the control group at days 3, 6,
and 10 p.i. A significant influence of treatment time on EROD
induction in the head kidney did not exist, that is, EROD levels
in the head kidneys of BaP-injected fish did not significantly
change from day 3 to day 10 p.i. The EROD activities in head
FIG. 1. EROD activities in microsomes of head kidney (A) and liver (B) from rainbow trout treated with BaP (25 mg/kg body weight, black columns) or corn
oil alone (carrier control, white columns), sampled at days 0, 3, 6, and 10 p.i. The values shown are mean values ± SE (bars) of eight animals per group.
*, **Significantly different from control group at a time (*p  0.01, **p  0.001) (Mann–Whitney U test).
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kidneys of BaP-treated fish at days 3, 6, and 10 p.i. were 4.2-,
4.1-, and 6.9-fold higher than those in control fish.
In liver, EROD activities of control fish accounted for 32.7,
9.7, 14.6, and 13.4 pmol resorufin/min/mg protein at days 0, 3,
6, and 10, respectively. There was no statistically significant
difference between these values. Control levels of hepatic
EROD activities were significantly higher than in the head
kidney. BaP treatment resulted in a significant induction of
hepatic EROD activities over control values at 3 (30-fold induc-
tion over control), 6 (20-fold), and 10 (16-fold) days p.i. (Fig.
1B). As in head kidney, a significant influence of treatment
time on EROD induction in liver did not exist, although head
kidney EROD activities showed an increase from day 3 to day
10 p.i., whereas hepatic EROD activities decreased during the
same period.
BaP Metabolites in Bile
To estimate the extent of BaP metabolism in the injected
trout, bile metabolites of BaP were analyzed by means of fixed
wavelength fluorescence spectroscopy. Although in control
fish, no BaP metabolites were detected in the bile, in BaP-
treated fish the amount of fluorescent BaP metabolites
accumulated in the bile continuously over the 10 days p.i.
Mean values were 459.3 fluorescence units (fu), 571.8 fu and
963.0 fu at days 3, 6, and 10 p.i., respectively. The calculated
mean daily increase of biliary BaP metabolites from day 0 to
day 3 was 153.1 fu per day (Dfu/day). This rate was ap-
proximately four times stronger than the rate found for the
period from day 3 to day 6 (Dfu/day ¼ 37.5), and about
1.5 times stronger than in the period from day 6 to day 10 (Dfu/
day ¼ 97.8). Significant correlations existed between the
hepatic EROD activities and the amount of BaP metabolites
in the bile of individual animals, both for each sampling day
(Fig. 2) and over the whole experimental period (Pearson
correlation; nEROD liver ¼ 24, nBaP metabolites ¼ 22; p ¼ 0.012).
No correlation was found between the EROD activities in the
head kidney and the BaP metabolites in the bile.
CYP1A Immunoblotting on Head Kidney and Liver
Microsomes
Immunoblotting was performed in order a) to confirm the
specificity of the C10-7 antibody against CYP1A of rainbow
trout, and b) to clarify if the BaP-induced increase of CYP1A at
the EROD catalytic level is accompanied by a corresponding
increase of CYP1A protein. In microsomes prepared from head
kidneys and livers of control trout, no immunoreactive protein
was detected. However, when microsomes from BaP-injected
fish were used, the C10-7 antibody detected one single protein
band of approximately 60 kDa weight (Fig. 3). The CYP1A-
positive protein was expressed in both tissues at 3, 6, and 10
days p.i. (Fig. 3). Although microsomal protein applied to the
Western Blots was fivefold higher from the head kidney than
from the liver, the CYP1A-positive protein bands obtained
with the head kidney microsomes were much smaller than
those of the liver. This agrees with the finding that EROD ac-
tivities in liver are much higher than in head kidney (see Fig. 1).
Immunohistochemical Localization of CYP1A in Liver and
Head Kidney Tissues
Using the C10-7 antibody, CYP1A immunostaining in the
liver of control trout was either nonexistent or very weak;
immunoreactivity was found in the cytoplasm of the hepato-
cytes, and in bile ductular cells (Fig. 4A). In BaP-treated trout,
strong CYP1A immunoreactivity was present in the hepato-
cytes, whereas an increase of CYP1 staining response in the
bile ductular cells was not evident (Fig. 4B). In the head kidney
of control fish no CYP1A immunoreactivity was observed (Fig.
5A). Strong immunoreactivity, however, was found in the head
kidneys of BaP-treated fish from day 3 p.i. onwards (Fig. 5B).
The staining was present in cells of the vascular endothelia and
in lymphoid cells, but not in endocrine (interrenal and chro-
maffin) cells. Two lymphoid cell types exhibited the highest
immunoreactivity for CYP1A, on the one hand cells with
a circular nucleus surrounded by a thin perinuclear layer of
cytoplasm (Fig. 6A), and on the other hand larger cells with a
FIG. 2. Amount of BaP metabolites (expressed as arbitrary fu) in bile of trout treated with BaP (25 mg/kg body weight) compared with hepatic EROD
activities of the same animals. Several days before as well as during the experiment the fish were not fed so that bile was not released but accumulated in the gall
bladder. Samples were obtained at 3 (A), 6 (B), and 10 days p.i. (C). The correlations between biliary BaP metabolites and EROD activities are significant.
CYP1A IN TROUT LEUKOCYTES 89
circular or oval nucleus and a larger cytoplasmic area (Fig. 6B).
The diameters of the first cell type ranged between 5 and 12 lm,
and of the second cell type up to a maximum size of 15 lm.
Double Immunostaining for CYP1A and Immune Cell Surface
Markers on Isolated Head Kidney Leukocytes
Head kidney leukocytes were prepared from control rainbow
trout and subjected to nuclear staining using DAPI (Figs. 7A
and 8A), staining for granulocyte or B-cell surface markers
(Figs. 7B and 8B, respectively), and CYP1A staining (Figs. 7C
and 8C, respectively). Isolated leukocytes of control rainbow
trout expressed no detectable CYP1A protein except for non-
specific surface staining of some immune cells. This finding
was corroborated by the doublestaining (Figs. 7D and 8D).
Head kidney leukocytes isolated from rainbow trout exposed to
BaP (Figs. 7E–H and 8E–H) showed strong CYP1A immuno-
reactivity (Figs. 7G and 8G). As evident from double
immunostaining, CYP1A was localized in leukocytes reacting
with the granulocyte surface marker (Fig. 7H) as well as in
leukocytes reacting with the B-cell marker (Fig. 8H). These
cells indeed displayed the typical morphology of granulocytes
or lymphocytes. The results provide strong evidence that head
kidney granulocytes and B cells of rainbow trout possess in-
ducible CYP1A. Importantly, the head kidney leukocyte pre-
parations of BaP-exposed trout contained cells that reacted
neither with the granulocyte nor with the B-cell marker, but
stained for CYP1A (Fig. 7H, arrowhead). This indicates that
additional leukocyte populations other than granulocytes and B
lymphocytes express inducible CYP1A. Further, among the B
cells and granulocytes, there appear to exist CYP1A-negative
subpopulations as not all B cells and granulocytes stained
positive for CYP1A (Figs. 9A–D).
DISCUSSION
The aims of this study were to examine (1) the (time-
dependent) induction of CYP1A catalytic activity and protein
by BaP in the head kidney of rainbow trout in comparison to
the liver as main organ of xenobiotic metabolism, (2) the
distribution of CYP1A protein among the various cell types
constituting the head kidney of rainbow trout, and (3) the
identification of CYP1A-positive leukocyte populations
FIG. 3. Immunoblotting of CYP1A protein in head kidney and liver tissue
of rainbow trout. The bands show CYP1A-immunoreactive protein of head
kidney and liver microsomes from rainbow trout treated with BaP (25 mg/kg
body weight, lanes 2, 4, 6) or corn oil (lanes 1, 3, 5) and sampled at 3 (lanes 1,
2), 6 (lanes 3, 4), and 10 (lanes 5, 6) days p.i., respectively. One hundred and
thirty-six micrograms microsomal protein of head kidney and 24 lg
microsomal protein of liver were added to each well, electrophoresed and
blotted as described in ‘‘Material and Methods.’’ The antibody used was the
mAb C10-7 against peptide 277–294 of rainbow trout CYP1A (Biosense).
FIG. 4. Immunohistochemical localization of CYP1A by mAb C10-7 in
liver of (A) control rainbow trout, and (B) rainbow trout treated with BaP
(25 mg/kg body weight), 3 days p.i. (A) In control fish, no or weak CYP1A
immunoreactivity is observed in hepatocytes (1) and epithelial cells of bile duct
(2). Note pigmented cells (3) within the periportal field. (B) Strong CYP1A
immunoreactivity is visible in hepatocytes (4), but no or very weak
immunostaining is present in epithelial cells of bile ducts (5).
FIG. 5. Immunohistochemical localization of CYP1A by mAb C10-7 in
head kidney of (A) control rainbow trout, and (B) rainbow trout treated with
BaP (25 mg/kg body weight), 3 days p.i. (A). In control trout, no
immunoreactivity is visible in lymphoid (1) and endocrine cells (2). (B) In
BaP-treated fish, strong immunoreactivity is present in several cells of lymphoid
cells (3), vascular endothelial cells (4), whereas no immunoreactivity is visible in
endocrine cells (5). Pigmented cells (black spots) are also clearly visible (6).
FIG. 6. Immunohistochemical staining of CYP1A by mAb C10-7 in head
kidney of rainbow trout treated with BaP (25 mg/kg body weight) at 3 days p.i.
(A, B) Two types of lymphoid cells exhibit the highest immunoreactivity for
CYP1A, one cell type with a circular nucleus surrounded by a thin perinuclear
layer of cytoplasm (A, arrows), and the other cell type with a circular or oval
nucleus and a relatively high amount of cytoplasm (B, arrows). In all sections
pigmented cells are clearly visible (arrowheads).
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of rainbow trout. The results from the BaP experiment clearly
show that head kidney tissue possesses inducible CYP1A, both
at the catalytic level and at the protein level. Time-dependency
of EROD induction did not significantly differ between liver
and head kidney, although in the liver maximum EROD values
were reached 6 days p.i. and decreased thereafter, whereas in
the head kidney, EROD levels continued to increase slightly
until 10 days p.i. Importantly, basal and induced CYP1A ex-
pression levels in the head kidney were by an order of
magnitude lower than CYP1A levels in the liver, and also the
induction was clearly lower. These findings on CYP1A in the
head kidney of rainbow trout agree well with previous
observations from the cyprinid species, medaka and carp
(Carlson et al., 2004a; Marionnet et al., 1997; Taysse et al.,
1998). When comparing microsomal xenobiotic metabolism
between trunk (excretory) and head kidney, Pesonen et al.
FIG. 7. Localization of CYP1A in head kidney granulocytes of rainbow trout. Control fish (A–D) and BaP-exposed fish (E–H) are shown. Nuclear staining
with DAPI (A, E). Specific immunoreactivity (Texas red) to granulocyte surface marker using mAb Q4E (B, F) and strong CYP1A immunoreactivity (FITC) in the
cytoplasm of leukocytes from BaP-treated fish (G). No CYP1A immunoreactivity is visible in leukocytes isolated from the head kidney of control fish (C). Overlay
of DAPI nuclear staining and double immunostaining of control (D) and BaP-exposed fish (H) confirms that granulocytes of BaP-exposed rainbow trout express
immunoreactive CYP1A (H, arrow). Some leukocytes did not react with the granulocyte marker, but stained for CYP1A (H, arrowhead) (scale bar: 10 lm).
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(1990) found that cytochrome P450 monooxygenase activities
were higher in the trunk kidney than in the head kidney, but the
activities of cytochrome P450–dependent enzymes of steroid
metabolism were higher in the head kidney.
Fish head kidney is a major hematopoietic and lymphoid
organ of fish. However, it is a heterogenous tissue containing,
in addition to the hematopoietic cells, also endocrine cells (in-
terrenal and chromaffin cells) and vascular endothelial cells.
Thus, the detection of CYP1A activity and protein in mi-
crosomes prepared from head kidney homogenates leads to the
question in which particular cell type(s) CYP1A is localized.
The results of the present study show that CYP1A protein is
expressed in the endothelia and in the hematopoietic part of the
rainbow trout head kidney. The vascular endothelial system is
FIG. 8. Localization of CYP1A in head kidney B lymphocytes of rainbow trout. Control fish (A–D) and BaP-exposed fish (E–H) are shown. Nuclear staining
with DAPI (A, E). Specific immunoreactivity (Texas red) for surface marker of B lymphocytes using both mAbs 4C10 and N2 (B, F) and strong CYP1A
immunoreactivity (FITC) in the cytoplasm of leukocytes prepared from BaP-treated fish (G). No CYP1A immunoreactivity is visible in leukocytes isolated from
the head kidney of control fish (C). Overlay of DAPI nuclear staining and double immunostaining of control (D) and BaP-exposed fish (H, arrows) confirms that B
lymphocytes of BaP-exposed rainbow trout express immunoreactive CYP1A (scale bar: 10 lm).
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known as a prominent site of CYP1A expression in fish tissues
(Sarasquete and Segner, 2000), what is in agreement with the
findings from the present study. More controversial is the
CYP1A expression in the endocrine cells. Although we ob-
served no CYP1A immunoreactivity in head kidney endocrine
cells of rainbow trout, neither in control nor in exposed fish,
Husøy et al. (1994) reported the presence of CYP1A
immunostaining in interrenal cells of beta-naphtoflavone-
treated cod, G. morhua. Whether this difference represents a
species difference or has other reasons remains to be resolved.
Also the findings on CYP1A expression in immune cells of fish
are conflicting. Absence of CYP1A immunoreactivity from
lymphoid cells was reported for the excretory kidney of scup
(Smolowitz et al., 1991; Stegeman et al., 1991), zebrafish
(Buchmann et al., 1993), and cod (Husøy et al., 1994), whereas
CYP1A-positive immune cells were reported to be present in
the hematopoietic tissue of the excretory kidney of European
flounder (Grinwis and van den Brandhof, 2001; Grinwis et al.,
2000) and medaka (Carlson et al., 2004a). The latter authors
found that CYP1A was present in subpopulations of mono-
nuclear cells of the trunk kidney, but did not identify the
precise nature of those subpopulations. With respect to the
head kidney, only Husøy et al. (1994) examined CYP1A
expression in hematopoietic cells, but did not observe CYP1A
immunoreactivity, neither in control fish nor in beta-naphtho-
flavone–treated cod. The results of the present study, however,
provide strong evidence for the presence of BaP-inducible
CYP1A in lymphoid cells of the rainbow trout head kidney.
These findings agree with the known expression of CYP
enzymes in hematopoietic tissues of mammals (Krovat et al.,
2000; Laupeze et al., 2002).
Having demonstrated that immune precursor cells of the
head kidney express inducible CYP1A protein, we aimed to
identify the nature of those cells. In mammalian leukocytes, the
presence of CYP1A has been demonstrated in peripheral blood
T and B lymphocytes, spleen lymphocytes, and lymphoblastoid
cells as well as in circulating monocytes and tissue macro-
phages (Baron et al., 1998; Grevenynghe et al., 2003;
Hukkanen et al., 1997; Krovat et al., 2000; Nohara et al.,
2006; Thurmond et al., 2000; Van den Heuvel et al., 1993;
Waithe et al., 1991). Morphology of the CYP1A-positive
lymphoid cells in head kidney sections of rainbow trout re-
sembled phagocyte- and lymphocyte-type cells (Lehmann and
Stührenberg, 1975). However, because morphological criteria
are not conclusive enough, we employed surface markers for
rainbow trout leukocytes to identify the CYP1A-positive im-
mune cells. Using double immunostaining with antibodies
against piscine CYP1A and against rainbow trout granulocytes
(mAbQ4E; Kuroda et al., 2000) and B lymphocytes
(mAb4C10, Thuvander et al., 1990; mAbN2, Fischer and
Köllner, 1994) we could demonstrate that granulocytes and B
lymphocytes of rainbow trout express inducible CYP1A.
Importantly, the immune cell suspensions prepared from trout
head kidney contained CYP1A-positive leukocytes, which reacted
neither with the granulocyte marker nor with the B-lymphocyte
marker. Based on theri morphology and the absence of staining by
both antibodies (mAB4C10, mABN2) against B-cells, tehse cells
may represent sIgM-negative lymphocytes. This could be T-cells
FIG. 9. Localization of CYP1A in head kidney B lymphocytes of BaP-exposed rainbow trout. Nuclear staining with DAPI (A), specific immunoreactivity
(Texas red) in B lymphocytes using both mAbs 4C10 and N2 (B), strong CYP1A immunoreactivity (FITC) in the cytoplasm of leukocytes (C), and the overlay (D)
are shown. There are two B lymphocytes, one of them expressing CYP1A (arrow), whereas the other one does not express CYP1A (arrowhead) (scale bar: 10 lm).
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or Natural Killer (NK) cells. However, since antibodies to stain
markers expressed on T- or NK-cells are not available, we cannot
unequivocally prove this assumption. Vice versa, we observed
immune cells staining for either the granulocyte or the B-cell
markers, but not with the CYP1A antibody. Thus, on the one
hand, granulocytes and B lymphocytes are not the only immune
cells of rainbow trout containing inducible CYP1A, and, on the
other hand, not all granulocytes and B lymphocyte are CYP1A-
positive but there appear to exist CYP1A-negative subpopula-
tions. In rainbow trout it was reported that head kidney
granulocytes are mainly neutrophils (Moritomo et al., 2003).
Because the vast majority of surface marker-defined granulocytes
were CYP1A-positive, we speculate that neutrophils constitute the
CYP1A-inducible granulocyte subpopulation of rainbow trout
head kidney. The presence of CYP1A-positive and -negative
subpopulations of B lymphocytes might be related to the presence
of different maturation stages of B lymphocytes in the head
kidney (Zwollo et al., 2005).
For mammalian systems, there exists clear evidence that
lymphoid cells possess inducible BaP metabolism (White et al.,
1994), and that the immunotoxic effects of BaP are related to
BaP metabolism and activation of oxidative and electrophilic
signaling pathways (Burchiel and Luster, 2001; Uno et al.,
2004, 2006). Our results confirm previous findings (Carlson
et al., 2004a, b; Grinwis and van den Brandhof, 2001; Grinwis
et al., 2000) that immune cells in fish hematopoietic tissues
possess inducible CYP1A protein and should be able to
metabolize BaP. Further evidence for the presence of bio-
transformation capabilities in fish immune cells comes from the
observation of DNA adducts in lymphoid and peripheral
immune cells of BaP-treated fish (Malmström et al., 2000;
Rose et al., 2001) as well as from the finding that enriched
leukocyte preparations from head kidney and spleen of spot,
Leiostomus xanthurus, were able to convert BaP into reactive
intermediates (Rutan and Faisal, 1994). The results from the
present study extend previous findings in that for the first time -
by means of double staining- the nature of CYP1A-positive
immune cells has been identified. This information can
contribute to better understand the mechanisms underlying
PAH immunotoxicity in fish. For instance, a typical immuno-
toxic response of fish to BaP exposure is a change in reactive
oxygen generation by granulocytes (Carlson et al., 2002b,
2004a; Holladay et al., 1998; Karrow et al., 2001; Reynaud
and Deschaux, 2006), an effect that could be caused by the
xenobiotic induction of CYP1A and associated alterations in
the prooxidant status of the granulocytes. Another hallmark of
BaP immunotoxicity in fish is reduced lymphocyte prolif-
eration and suppressed number of antibody forming cells
(Carlson et al., 2002a, b, 2004b), which may be related to
cytotoxicity arising from the BaP metabolism in B lympho-
cytes. Similarly, for mammals it has been shown that immune
cell metabolism of PAHs causes a decrease of progenitor B
lymphocytes and, consequently, impaired humoral immunity
(Galván et al., 2003, 2006).
In conclusion, this study shows that CYP1A is inducible in
rainbow trout head kidney by BaP treatment. CYP1A is
localized in head kidney vascular endothelia and in immune
cells of the hematopoietic part of the head kidney, more
specifically in granulocytes and B lymphocytes. The advance-
ment of the present work, that is, the allocation of CYP1A to
specific immune cell types, identifies those immune cell
populations that are able to execute local PAH metabolism,
and, at the same time, should be the immediate targets of PAH
immunotoxic action. Another interesting perspective for future
investigations arising from the findings of the present study is
the observation of CYP1A-negative and CYP1A-positive B
lymphocytes and granulocytes in rainbow trout, pointing to the
existence of functionally different leukocyte subpopulations—
an aspect that has been hardly ever studied in fish.
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Fischer, U., and Köllner, B. (1994). Preparation of a B-cell and monocyte free
thymocyte suspension. In Techniques in Fish Immunology (J. S. Stolen,
T. C. Fletcher, D. P. Anderson, B. S. Roberson, and W. B. Van Muiswinkel,
Eds.), pp. 27–33. SOS Publications, Fair Haven, NJ.
Galván, N., Jaskula-Sztul, R., MacWilliams, P. S., Czuprynski, C. J., and
Jefcoate, C. R. (2003). Bone marrow cytotoxicity of benzo(a)pyrene is
dependent on CYP1B1 but is diminished by Ah receptor-mediated induction
of CYP1A in liver. Toxicol. Appl. Pharmacol 193, 84–96.
Galván, N., Page, T. J., Czuprynski, C. J., and Jefcoate, C. R. (2006).
Benzo[a]pyrene and 7,12,dimethylbenz[a]anthracene differentially affect
bone marrow cells of the lymphoid and myeloid lineages. Toxicol. Appl.
Pharmacol. 213, 105–116.
Galván, N., Teske, D. E., Zhou, G., Moorthy, B., MacWilliams, P. S.,
Czuprynski, C. J., and Jefcoate, C. R. (2005). Induction of CYP1A1 and
CYP1B1 in liver and lung by benzo[a]pyrene and 7,12-dimethylbenz[a]an-
thracene do not affect distribution of polycyclic hydrocarbons to target
tissue: Role of AhR and CYP1B1 in bone marrow cytotoxicity. Toxicol.
Appl. Pharmacol. 202, 244–257.
Grevenynghe, J., vanRion, S., Le Ferrec, E., Le Vee, M., Amiot, L.,
Fauchet, R., and Fardel, O. (2003). Polycyclic aromatic hydrocarbons
inhibit differentiation of human monocytes into macrophages. J. Immunol.
170, 2374–2381.
Grinwis, G. C. M., Besselink, H. T., van den Brandhof, E. J., Bulder, A. S.,
Engelsma, M. Y., Kuiper, R. V., Wester, P. W., Vaal, M. A., Vethaak, A. D.,
and Vos, J. G. (2000). Toxicity of TCDD in European flounder (Platichthys
flesus) with emphasis on histopathology and cytochrome P450 1A induction
in several organ systems. Aquat. Toxicol. 50, 387–401.
Grinwis, G. C. M., and van den Brandhof, E. J. (2001). Toxicity of PCB-126 in
European flounder (Platichthys flesus) with emphasis on histopathology and
cytochrome P4501A induction in several organ systems. Arch. Toxicol. 75,
80–87.
Hart, L. J., Smith, S. A., Smith, B. J., Robertson, J., Besteman, E. G., and
Holladay, S. D. (1998). Substance immunotoxic effects of the polycyclic
aromatic hydrocarbon 7,12-dimethylbenzanthracene (DMBA) on spleen and
pronephros leukocytic cell counts and phagocytic cell activity in tilapia
(Oreochromis niloticus). Aquat. Toxicol. 41, 17–29.
Hoeger, B., Koellner, B., Kotterba, G., van den Heuvel, M. R., Hirtzfeld, B.,
and Dietrich, D. R. (2004). Influence of chronic exposure to treated sewage
effluent on the distribution of white blood cell populations in rainbow trout
(Oncorhynchus mykiss) spleen. Toxicol. Sci. 82, 97–105.
Holladay, S. D., Smith, S. A., Besteman, E. G., Deyab, A. S. M. I.,
Gogal, R. M., Hrubec, T., Robertson, J. L., and Ahmed, S. A. (1998).
Benzo[a]pyrene-induced hypocellularity of the pronephros in tilapia
(Oreochromis niloticus) is accompanied by alternations in stromal and
parenchymal cells and by enhanced immune cell apoptosis. Vet. Immunol.
Immunopathol. 64, 69–82.
Hukkanen, J., Hakkola, J., Anttila, S., Piipari, R., Karjalainen, A.,
Pelkonen, O., and Raunio, H. (1997). Detection of mRNA encoding
xenobiotic-metabolizing cytochrome P450s in human bronchoalveolar
macrophages and peripheral blood lymphocytes. Mol. Carcinog. 20,
224–230.
Husøy, A. M., Myers, M. S., Willis, M. L., Collier, T. K., Celander, M., and
Goksøyr, A. (1994). Immunohistochemical localization of CYP1A
and CYP3A-like isozymes in hepatic and extrahepatic tissues of Atlantic
cod (Gadus morhua L.) a marine fish. Toxicol. Appl. Pharmacol. 129,
294–308.
Karrow, N. A., Boermans, H. J., Dixon, D. G., Hontella, A., Solomon, K. R.,
Whyte, J. J., and Bols, N. C. (1999). Characterizing the immunotoxicity of
creosote to rainbow trout (Oncorhynchus mykiss): A microcosm study.
Aquat. Toxicol. 45, 223–239.
Karrow, N. A., Bols, N. C., Whyte, J. J., Solomon, K. R., Dixon, D. G., and
Boermans, H. J. (2001). Effects of creosote exposure on rainbow trout
pronephros phagocytic activity and the percentage of lymphoid B cells. J.
Toxicol. Environ. Health A 63, 363–381.
Krovat, B. C., Tracy, J. H., and Omiecinski, C. J. (2000). Fingerprinting of
cytochrome P450 and microsomal epoxide hydrolase gene expression in
human blood cells. Toxicol. Sci. 55, 352–360.
Kuroda, A., Okamoto, N., and Fukuda, H. (2000). Characterization of
monoclonal antibodies against antigens shared with neutrophils and macro-
phages in rainbow trout (Oncorhynchus mykiss). Fish Pathol. 35, 205–213.
Laemmli, U. K. (1970). Cleavage of structural proteins during the assembly of
the head of bacteriophage T4. Nature 227, 680–685.
Laupeze, B., Amiot, L., Sparfel, L., Le Ferrec, E., Fauchet, R., and Fardel, O.
(2002). Polycyclic aromatic hydrocarbons affect functional differentiation
and maturation of human monocyte-derived dendritic cells. J. Immunol. 168,
2652–2658.
Lehmann, J., and Stührenberg, F. J. (1975). Leukopoese. In Haematologisch-
serologische Substratuntersuchungen an der Regenbogenforelle (Salmo
gairdneri Richardson), pp. 43–84. Kaltenmeier & Söhne, Krefeld-Hüls,
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